Referring Hospitalized Smokers to Outpatient Quit Services: A Randomized Trial
Introduction
Cigarette smoking is the leading cause of preventable death and disease in the U.S., resulting in 480,000 deaths and more than $170 billion in excess medical care expenditures per year.1, 2 Although smoking rates have declined substantially since the late 1990s,1, 3 more needs to be done. Counseling programs to help smokers quit are effective and highly cost effective, particularly when combined with cessation medications.3, 4, 5
The forced abstinence associated with a hospital stay, particularly in smoke-free facilities, represents an opportunity to initiate professional treatment and link patients with multiple intervention contacts after discharge. This approach can lead to significant increases in quit rates.3, 6, 7, 8, 9, 10, 11, 12 In 2012, the Joint Commission recognized the importance of treating tobacco dependence for all hospitalized smokers by broadening the requirements for effective treatment to include referral to outpatient services and follow-up.13, 14
Creating an integrated clinical pathway—from inpatient assistance to outpatient cessation services—is challenging for any healthcare delivery system, even integrated organizations that also provide outpatient and behavioral health services. An effective model includes in-hospital treatment by trained professionals whose primary responsibility is tobacco cessation15 and a hospital-managed follow-up program for continuity of care.16 Integrating inpatient and outpatient cessation services is much more daunting for free-standing community and academic hospitals that serve patients who are potentially covered by dozens of health insurance plans. Typically, insurance plans cover inpatient services, but prior authorization is needed for outpatient coverage.
In 2010, NIH funded seven clinical trials to evaluate the effectiveness and cost effectiveness of hospital-based smoking-cessation programs that linked smokers to post-discharge outpatient interventions.16 Investigators from each study and NIH formed the Consortium of Hospitals Advancing Research on Tobacco to create common data elements that would enable data pooling and analyses across studies. This study presents data from the Inpatient Technology-Supported Assisted Referral study (U01 HL105231; clinical trials registration, NCT01236079), a patient-randomized clinical effectiveness trial. Each participant received a comprehensive bedside tobacco-cessation consult as part of usual care (UC), delivered by a trained tobacco treatment specialist (TTS): a physician assistant, research registered nurse, or health educator, depending on the study site. Patients also received information about outpatient cessation programs and medications. Patients randomized to the study treatment also received ARs for post-discharge tobacco-cessation services (counseling and medications) plus interactive voice recognition support (AR+IVR). IVR was used to provide efficient post-discharge follow-up for treatment plans initiated during hospitalization.17, 18, 19
The Inpatient Technology-Supported Assisted Referral study tested the hypothesis that adding an AR to outpatient quit services and IVR follow-up to a bedside smoking-cessation consultation would significantly increase self-reported 30-day abstinence at 6-month follow-up compared to the bedside consult service only. The overall goal of the study was to demonstrate that combining tobacco treatment expertise with electronic health systems technology could effectively link in-hospital tobacco dependence treatment to cost-effective outpatient follow-up care, thus increasing patient’s use of outpatient quit programs and medications compared to UC. A detailed description of the study protocol is available elsewhere.20
Section snippets
Methods
A randomized controlled clinical effectiveness trial was conducted with 900 patients who had been admitted to one of three large hospitals. All study participants received bedside tobacco-cessation consults as part of UC, and 597 patients were randomly selected to receive a TTS-delivered AR+IVR. Participants completed baseline and 6-month follow-up assessments, with a $50 incentive for completing follow-up. Blinded study staff arranged and conducted the assessments. Intervention fidelity was
Results
Study participants were recruited over 24 months (November 2011–November 2013). Follow-up assessments were completed in August 2014, and data analysis was completed in 2015. TTSs conducted initial electronic medical record prescreening for 3,828 hospitalized adult smokers who met study eligibility criteria (Figure 1). Prescreening identified 2,908 (76%) patients who were eligible for a bedside quit consult and study recruitment visit. TTSs identified 986 (34%) patients who were screened
Discussion
This trial demonstrated that dedicated TTSs can provide intensive cessation counseling lasting nearly 20 minutes as part of an integrated hospital care delivery team, and that most smokers will accept an AR offer as part of this service. The bedside intervention was delivered as planned. The additional 2–3 minutes spent with patients in the AR+IVR group suggest that adding an AR is not burdensome. Unfortunately, the referral did not increase the use of outpatient counseling programs compared to
Conclusions
Post-hospitalization cessation counseling and medications have proven to increase abstinence, decrease hospitalizations, and improve mortality.6, 9 Despite being accepted by patients, the AR program had little effect on patient-reported counseling and a small effect on medication use compared to usual care. Thus, more needs to be done to ensure that the linkage to outpatient services is robust.
Acknowledgments
The authors wish to thank Dr. William Riley at the Office of Behavioral and Social Sciences Research, NIH; Consortium of Hospitals Advancing Research on Tobacco members; staff at Kaiser Sunnyside Medical Center, Legacy Emanuel Hospital, and Oregon Health and Science University Hospital; and tobacco treatment specialists Christina Carlson, Deborah Conn, and Anya Hill.
Funding was provided by the National Heart, Lung, and Blood Institute (U01 HL105231; clinical trials registration, NCT01236079).
References (36)
- et al.
Annual healthcare spending attributable to cigarette smoking
Am J Prev Med
(2015) - et al.
The top priority: building a better system for tobacco-cessation counseling
Am J Prev Med
(2006) - et al.
The TEAM project: the effectiveness of smoking cessation interventions with hospital patients
Prev Med
(2005) - et al.
Intensive smoking cessation intervention reduces mortality in high-risk smokers with cardiovascular disease
Chest
(2007) - et al.
Interactive voice response telephony to promote smoking cessation in patients with heart disease: a pilot study
Patient Educ Couns
(2007) EuroQol: the current state of play
Health Policy
(1996)- et al.
Consortium of Hospitals Advancing Research on Tobacco (CHART). Fidelity monitoring across the seven studies in the Consortium of Hospitals Advancing Research on Tobacco (CHART)
Tob Induc Dis
(2015) The Health Consequences of Smoking: 50 Years of Progress: A Report of the Surgeon General
(2014)- et al.
Treating Tobacco Use and Dependence: 2008 Update. Clinical Practice Guideline
(May 2008) Strategies to help a smoker who is struggling to quit
JAMA
(2012)
Interventions for smoking cessation in hospitalised patients
Cochrane Database Syst Rev
Smoking cessation in hospitalized patients—results of a randomized trial
Arch Int Med
Randomised controlled trial of smoking cessation intervention after admission for coronary heart disease
BMJ
Smoking cessation after acute myocardial infarction: Effects of a nurse-managed intervention
Ann Int Med
A smoking-cessation intervention for hospital patients
Med Care
Can smokers switch from a hospital-based to a community-based stop smoking service? An open-label, randomized trial comparing three referral schemes
Nicotine Tob Res
Cited by (10)
Effects of post-discharge counseling and medication utilization on short and long-term smoking cessation among hospitalized patients
2019, Preventive Medicine ReportsCitation Excerpt :Providing smoking cessation medications for patients as an adjunct to counseling significantly improves long term quit rates (Fiore et al., 2008). A number of studies have examined methods for implementing these two elements of care into hospital treatment and post-discharge care planning (Sherman et al., 2016; Rigotti et al., 2016; Rigotti and Stoney, 2016; Richter et al., 2016; Harrington et al., 2016; Fellows et al., 2016; Duffy et al., 2016; Cummins et al., 2016). Post-discharge smoking cessation treatment providing automated telephone interactive voice response (IVR) counseling calls and free medication increased biochemically verified quit rates by almost two-fold (26% vs. 15%; RR 1.71, 95% CI, 1.14–2.56) in a single site study.
CHARTing the Future Course of Tobacco-Cessation Interventions for Hospitalized Smokers
2016, American Journal of Preventive MedicineHospital-Initiated Smoking Cessation Among Patients Admitted with Behavioral Health Conditions
2024, Journal of General Internal MedicineProactive Referral to Behavioral Smoking Cessation Programs by Healthcare Staff: A Systematic Review
2023, Nicotine and Tobacco Research
This article is part of a theme section titled Implementing Tobacco Cessation Interventions for Hospitalized Smokers